Advertisement
Research Article|Articles in Press

Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials

Published:December 10, 2022DOI:https://doi.org/10.1016/j.cardfail.2022.11.008

      Highlights

      • More than 1 in 10 trials reported outcomes inconsistent with those prespecified.
      • The majority of the inconsistencies favored statistically significant findings.
      • Single-center recruitment was associated with inconsistent outcome reporting.

      ABSTRACT

      Background

      Randomized controlled trials (RCTs) may report outcomes different from those prespecified on trial-registration websites, protocols and statistical analysis plans (SAPs). This study sought to investigate the prevalence and characteristics of heart failure (HF) RCTs that report outcomes different from those prespecified.

      Methods and Results

      MEDLINE via PubMed was searched to include phase II–IV HF RCTs in 9 high-impact journals from 2010 to 2020. Outcomes reported in trial publications were compared with prespecified outcomes in protocols, registration websites and SAPs. We used the χ2 or Fisher exact test to analyze correlations between trial characteristics and inconsistencies. Among 216 trials, 32 inconsistencies were observed in 28 trials (13.0%). Among 32 inconsistencies, 2 (6.3%) pertained to omission of prespecified primary outcomes, 4 (12.5%) to omission of prespecified secondary outcomes, 2 (6.3%) to changing prespecified primary outcomes to secondary outcomes, and 2 (6.3%) to changing prespecified secondary outcomes to primary outcomes. Of the inconsistencies, 3 (9.4%) pertained to addition of new primary outcomes, 17 (53.1%) to addition of new secondary outcomes, and 2 (6.3%,) to changes in the timing of assessment of primary outcomes. The majority of the inconsistencies favored statistically significant findings; 78 (36.1%) were registered retrospectively. Single-center recruitment was associated with outcome inconsistencies (β = -0.14; 95% CI, -0.22 – -0.01; P = 0.035).

      Conclusions

      More than 1 in 10 trials reported outcomes inconsistent with those specified in trial registration websites, SAPs and protocols. An action plan is warranted to minimize selective reporting and improve transparency.

      Graphical abstract

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dwan K
        • Altman DG
        • Arnaiz JA
        • Bloom J
        • Chan A
        • Cronin E,
        • et al.
        Systematic review of the empirical evidence of study publication bias and outcome reporting bias.
        PLoS O. ne 2008; 3: e3081https://doi.org/10.1371/journal.pone.0003081
        • Faunce TA
        • Buckley NA.
        Of consents and CONSORTS: reporting ethics, law, and human rights in RCTs involving monitored overdose of healthy volunteers pre and post the “consort” guidelines.
        J Toxicol. 2003; 41: 93-99https://doi.org/10.1081/CLT-120019120
        • Ewart R
        • Lausen H
        • Millian N.
        Undisclosed changes in outcomes in randomized controlled trials: an observational study.
        Ann Fam Med. 2009; 7: 542-546https://doi.org/10.1370/afm.1017
        • Moher D
        • Hopewell S
        • Schulz KF
        • Montori V
        • Gøtzsche PC
        • Devereaux PJ,
        • et al.
        CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
        BMJ (Clin Res). 2010; 340: c869https://doi.org/10.1136/bmj.c869
        • DeAngelis CD
        • Drazen JM
        • Frizelle FA
        • Haug C
        • Hoey J
        • Horton R,
        • et al.
        Clinical trial registration: a statement from the International Committee of Medical Journal Editors.
        JAMA. 2004; 292: 1363-1364https://doi.org/10.1001/jama.292.11.1363
        • de Oliveira GS
        • Jung MJ
        • McCarthy RJ.
        Discrepancies between randomized controlled trial registry entries and content of corresponding manuscripts reported in anesthesiology journals.
        Anesth Analges. 2015; 121: 1030-1033https://doi.org/10.1213/ANE.0000000000000824
        • Hardt JLS
        • Metzendorf MI
        • Meerpohl JJ.
        Surgical trials and trial registers: a cross-sectional study of randomized controlled trials published in journals requiring trial registration in the author instructions.
        Trials. 2013; 14: 407https://doi.org/10.1186/1745-6215-14-407
        • Jones CW
        • Platts-Mills TF.
        Quality of registration for clinical trials published in emergency medicine journals.
        Ann Emerg Med. 2012; 60 (e1): 458-464https://doi.org/10.1016/j.annemergmed.2012.02.005
        • Nankervis H
        • Baibergenova A
        • Williams HC
        • Thomas KS.
        Prospective registration and outcome-reporting bias in randomized controlled trials of eczema treatments: a systematic review.
        J Invest Dermatol. 2012; 132: 2727-2734https://doi.org/10.1038/jid.2012.231
        • Rasmussen N
        • Lee K
        • Bero L.
        Association of trial registration with the results and conclusions of published trials of new oncology drugs.
        Trials. 2009; 10: 116https://doi.org/10.1186/1745-6215-10-116
        • Rayhill ML
        • Sharon R
        • Burch R
        • Loder E.
        Registration status and outcome reporting of trials published in core headache medicine journals.
        Neurology. 2015; 85: 1789-1794https://doi.org/10.1212/WNL.0000000000002127
        • Howard B
        • Scott JT
        • Blubaugh M
        • Roepke B
        • Scheckel C
        • Vassar M.
        Systematic review: outcome reporting bias is a problem in high impact factor neurology journals.
        Plos One. 2017; 12 (Janigro D, ed)e0180986https://doi.org/10.1371/journal.pone.0180986
        • Mathieu S
        • Boutron I
        • Moher D
        • Altman DG
        • Ravaud P.
        Comparison of registered and published primary outcomes in randomized controlled trials.
        JAMA. 2009; 302: 977-984https://doi.org/10.1001/jama.2009.1242
        • Lancee M
        • Lemmens CMC
        • Kahn RS
        • Vinkers CH
        • Luykx JJ.
        Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs.
        Transl Psych. 2017; 7: e1232https://doi.org/10.1038/tp.2017.203
        • Williamson PR
        • Altman DG
        • Bagley H
        • Barnes KL
        • Blazeby JM
        • Brookes ST
        • et al.
        The COMET Handbook: version 1.0.
        Trials. 2017; 18: 1-50https://doi.org/10.1186/s13063-017-1978-4
      1. ICTRP Search Portal. Accessed February 26, 2021. https://apps.who.int/trialsearch/

      2. ANZCTR. Accessed February 26, 2021. http://www.anzctr.org.au/TrialSearch.aspx

      3. Home - ClinicalTrials.gov. Accessed February 26, 2021. https://clinicaltrials.gov/

      4. ISRCTN Registry. Accessed February 26, 2021. https://www.isrctn.com/

      5. Clinical Trials Register. Accessed March 2, 2021. https://www.clinicaltrialsregister.eu/ctr-search/search

        • Chan AW
        • Hróbjartsson A
        • Haahr MT
        • Gøtzsche PC
        • Altman DG.
        Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
        JAMA. 2004; 291: 2457-2465https://doi.org/10.1001/jama.291.20.2457
        • Mathieu S
        • Chan AW
        • Ravaud P.
        Use of trial register information during the peer review process.
        PLoS One. 2013; 8: e59910https://doi.org/10.1371/journal.pone.0059910
        • Godlee F.
        Clinical trial data for all drugs in current use.
        BMJ (Online). 2012; 345: e7304https://doi.org/10.1136/bmj.e7304
        • Herson J.
        Strategies for dealing with fraud in clinical trials.
        Int J Clin Oncol. 2015; 21: 22-27https://doi.org/10.1007/S10147-015-0876-6
      6. Spence O, Hong K, Uba RO, Doshi P. Availability of study protocols for randomized trials published in high-impact medical journals: a cross-sectional analysis. Clin Trials 2019;17:99–105. https://doi.org/101177/1740774519868310.

        • Dwan K
        • Gamble C
        • Williamson PR
        • Altman DG.
        Reporting of clinical trials: a review of research funders’ guidelines.
        Trials. 2008; 9: 66https://doi.org/10.1186/1745-6215-9-66
        • Dal-Ré R
        • Caplan AL.
        Time to ensure that clinical trial appropriate results are actually published.
        Eur J Clin Pharmacol. 2014; 70: 491-493https://doi.org/10.1007/s00228-013-1635-0
        • Smith SM
        • Dworkin RH.
        Prospective clinical trial registration: not sufficient, but always necessary.
        Anaesthesia. 2018; 73: 538-541https://doi.org/10.1111/anae.14189
        • Jones PM
        • Chow JTY
        • Arango MF
        • Fridfinnson JA
        • Gai N
        • Lam K,
        • et al.
        Comparison of registered and reported outcomes in randomized clinical trials published in anesthesiology journals.
        Anesthes Analges. 2017; 125: 1292-1300https://doi.org/10.1213/ANE.0000000000002272
        • Nicholls M.
        Funding of cardiovascular research in the USA.
        Eur Heart J. 2018; 39: 3629-3631https://doi.org/10.1093/eurheartj/ehy638